CAS Medical Systems Inc  

(Public, NASDAQ:CASM)   Watch this stock  
Find more results for CASM
-0.03 (-1.31%)
Apr 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.20 - 2.30
52 week 1.21 - 2.50
Open 2.24
Vol / Avg. 8,630.00/34,099.00
Mkt cap 43.87M
P/E     -
Div/yield     -
EPS -0.67
Shares 19.41M
Beta 0.54
Inst. own 43%

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -53.51% -47.28%
Operating margin -52.06% -47.70%
EBITD margin - -45.84%
Return on average assets -65.69% -53.75%
Return on average equity - -
Employees 104 -
CDP Score - -


44 East Industrial Road
United States - Map
+1-203-4886056 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


CAS Medical Systems, Inc. (CASMED) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products that is vital to patient care. The Company's products include the FORE-SIGHT Absolute Tissue Oximeter and sensors, and the Company's Traditional Monitoring products which include MAXNIBP blood pressure measurement technology, bedside monitoring products, and neonatal vital signs supplies. In addition to Tissue Oximetry products, CASMED provides a series of traditional vital signs monitoring products and services to clinicians around the world. The Company�s vital signs monitoring products are sold within the United States via manufacturer�s representatives and distributors. Outside of the United States, sales are conducted through distributors in Europe, Africa, the Middle East, Pacific Rim, Latin America and Canada.

Officers and directors

Thomas M. Patton President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Jeffrey A. Baird Chief Financial Officer, Secretary
Age: 52
Bio & Compensation  - Reuters
Karen Harris-Coleman Executive Vice President - International Sales
Bio & Compensation  - Reuters
Paul B. Benni Chief Scientific Officer
Age: 45
Bio & Compensation  - Reuters
John R. Gamelin Ph.D. Vice President - Research & Development
Age: 47
Bio & Compensation  - Reuters
Brian J. Wagner Chief Commercial Officer
Bio & Compensation  - Reuters
James E. Thomas Lead Independent Director
Age: 52
Bio & Compensation  - Reuters
Lawrence S. Burstein Independent Director
Age: 70
Bio & Compensation  - Reuters
Gregory P. Rainey Independent Director
Age: 60
Bio & Compensation  - Reuters
Kathleen A. Tune Independent Director
Age: 48
Bio & Compensation  - Reuters